Skip to main content

Advertisement

Log in

Patterns of recurrence and outcome in patients with surgically resected small cell lung cancer

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

Although prophylactic cranial irradiation (PCI) in limited-stage (LS) small cell lung cancer (SCLC) patients who are surgically resected and treated with adjuvant chemotherapy is considered to be a reasonable treatment option, the efficacy of PCI for those patients remains unclear.

Methods

The records of 28 patients with SCLC undergoing curative surgery at the Aichi Cancer Center Hospital between 1995 and March 2008 were retrospectively reviewed to assess patterns of relapse and overall survival.

Results

The patients were 27 men and 1 woman. Eight patients underwent induction chemotherapy. Fourteen patients (50%) had pathologic stage (p-stage) I disease, 7 patients (25%) had p-stage II, and 7 patients (25%) had p-stage III. Nineteen patients underwent adjuvant chemotherapy and one patient received adjuvant chemoradiotherapy. There were a total of 13 deaths and 8 were disease-related. Most patients developed hematogenous distant metastases before their death. The 5-year overall probability of survival was 47%. Ten (36%) of the 28 patients had a relapse. Two had a local relapse alone, one patient had combined local and distant relapses, and seven patients had distant metastases alone as their first site of failure. Four patients with p-stage II/III disease developed brain metastases with a cumulative incidence at 1 and 2 years of 25 and 36%, respectively.

Conclusions

Our retrospective study suggested that PCI might have a role in surgically resected patients with p-stage II/III SCLC because of their relatively high frequency of brain metastasis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Ward E et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71–96

    Article  PubMed  Google Scholar 

  2. Statistics and Information Department, Minister’s Secretariat, Ministry of Health, Labour and Welfare (2009) Vital statistics of Japan. Health and Welfare Statistics Association, Tokyo

    Google Scholar 

  3. Govindan R, Page N, Morgensztern D et al (2006) Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 24:4539–4544

    Article  PubMed  Google Scholar 

  4. Turrisi AT 3rd, Kim K, Blum R et al (1999) Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 340:265–271

    Article  PubMed  CAS  Google Scholar 

  5. Noda K, Nishiwaki Y, Kawahara M et al (2002) Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 346:85–91

    Article  PubMed  CAS  Google Scholar 

  6. Mountain CF (1978) Clinical biology of small cell carcinoma: relationship to surgical therapy. Semin Oncol 5:272–279

    PubMed  CAS  Google Scholar 

  7. Kreisman H, Wolkove N, Quoix E (1992) Small-cell lung cancer presenting as a solitary pulmonary nodule. Chest 101:225–231

    Article  PubMed  CAS  Google Scholar 

  8. Koletsis EN, Prokakis C, Karanikolas M et al (2009) Current role of surgery in small cell lung carcinoma. J Cardiothorac Surg 4:30–35

    Article  PubMed  Google Scholar 

  9. Hardy J, Smith I, Cherryman G et al (1990) The value of computed tomographic (CT) scan surveillance in the detection and management of brain metastases in patients with small-cell lung cancer. Br J Cancer 62:684–686

    Article  PubMed  CAS  Google Scholar 

  10. Nugent JL, Bunn PA Jr, Matthews MJ et al (1979) CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival. Cancer 44:1885–1893

    Article  PubMed  CAS  Google Scholar 

  11. Blanchard P, Le Pechoux C (2010) Prophylactic cranial irradiation in lung cancer. Curr Opin Oncol 22:94–101

    Article  PubMed  Google Scholar 

  12. Auperin A, Arriagada R, Pignon JP et al (1999) Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 341:476–484

    Article  PubMed  CAS  Google Scholar 

  13. Slotman B, Faivre-Finn C, Kramer G et al (2007) Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 357:664–672

    Article  PubMed  CAS  Google Scholar 

  14. Travis WD, Brambilla E, Muller-Hermelink HK et al (2004) Pathology and genetics of tumours of the lung, pleura, thymus and heart. IARC Press, Lyon

    Google Scholar 

  15. International Union Against Cancer, Sobin LHWC (1997) TNM classification of malignant tumours (UICC). Wiley-Liss, New York

    Google Scholar 

  16. Vallieres E, Shepherd FA, Crowley J et al (2009) The IASLC lung cancer staging project: proposals regarding the relevance of TNM in the pathologic staging of small-cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol 4:1049–1059

    Google Scholar 

  17. Asamura H, Goya T, Koshiishi Y et al (2008) A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers. J Thorac Oncol 3:46–52

    Article  PubMed  Google Scholar 

  18. Anraku M, Waddell TK (2006) Surgery for small-cell lung cancer. Semin Thorac Cardiovasc Surg 18:211–216

    Article  PubMed  Google Scholar 

  19. Nakamura H, Kato Y, Kato H (2004) Outcome of surgery for small-cell lung cancer—response to induction chemotherapy predicts survival. Thorac Cardiovasc Surg 52:206–210

    Article  PubMed  CAS  Google Scholar 

  20. Tsuchiya R, Suzuki K, Ichinose Y et al (2005) Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I–IIIa small-cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). J Thorac Cardiovasc Surg 129:977–983

    Article  PubMed  CAS  Google Scholar 

  21. Arriagada R, Le Chevalier T, Riviere A et al (2002) Patterns of failure after prophylactic cranial irradiation in small-cell lung cancer: analysis of 505 randomized patients. Ann Oncol 13:748–754

    Article  PubMed  CAS  Google Scholar 

  22. Gaspar LE, Chansky K, Albain KS et al (2005) Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group. J Clin Oncol 23:2955–2961

    Article  PubMed  Google Scholar 

  23. Wolstenholme V, Hawkins M, Ashley S et al (2008) HER2 significance and treatment outcomes after radiotherapy for brain metastases in breast cancer patients. Breast 17:661–665

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported in part by a Grant-in-Aid from the Japan Society for Promotion of Science, and a grant from the Aichi Cancer Research Foundation to Y Horio.

Conflict of interest

The authors declare no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshitsugu Horio.

About this article

Cite this article

Ogawa, S., Horio, Y., Yatabe, Y. et al. Patterns of recurrence and outcome in patients with surgically resected small cell lung cancer. Int J Clin Oncol 17, 218–224 (2012). https://doi.org/10.1007/s10147-011-0277-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-011-0277-4

Keywords

Navigation